Ignite Creation Date:
2024-05-06 @ 5:51 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05458700
Status:
RECRUITING
Last Update Posted:
2024-02-21
First Post:
2022-05-20
Brief Title:
POS-cUTI Study on Complicated Urinary Tract Infections
Sponsor:
European Clinical Research Alliance for Infectious Diseases ECRAID
Organization:
European Clinical Research Alliance for Infectious Diseases ECRAID
Study Overview
Official Title:
POS-cUTIPerpetual Observational Study on Complicated Urinary Tract Infections
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Urinary tract infections UTI are among the most common infectious diseases and the most frequent source of community healthcare-associated and nosocomial bacteraemia They are associated with significant morbidity and mortality Due to the high frequency of UTI they have a major impact on antibiotic use and the antimicrobial resistance of prominent UTI pathogens is of recognised importance Therefore UTIs and particularly complicated urinary tract infections cUTIs are a target for repurposing of old and neglected drugs new drug development and non-antibiotic therapeutic and preventive approaches
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None